Llanes 2004 Los Angeles Motor Scale (LAMS): facial droop 0 absent / 1 present + arm drift 0 absent / 1 drifts down / 2 falls rapidly + grip 0 normal / 1 weak / 2 no grip. Max 5. Point values assigned to LAPSS motor items. Deterministic published arithmetic with citation; not NIHSS, not a stroke diagnosis or thrombolysis order. magent does not examine the patient.

Lansky 1987 Play-Performance Scale: caller-assigned integer 0, 10, 20, 30, 40, 50, 60, 70, 80, 90, or 100 from parent-rated play over the past week (fully active; minor physical restriction; tires more quickly; restricted play; quieter activities; lying around, quiet play; mostly in bed; bedbound; often sleeping; no play; unresponsive). Grade 0 is scored. Returns score, max 100, and a stable label. Not a performance-status assignment, not Karnofsky, not ECOG; magent does not observe the child.

Leibovich 2018 histology-specific RCC models after surgery. Required histology clear_cell, papillary, or chromophobe. ccRCC PFS points (2010 TNM): t1a/t1b/t2a 0, t2b 2, t3a-t3c 3, t4 4; nx/n0 0, n1 2; size ≥10 cm 1; grade 1-2 0, 3 1, 4 3; necrosis 2; max 12; risk low 0-2, intermediate 3-5, high ≥6. Papillary and chromophobe return the 2018 three PFS groups (score 0-2). Not SSIGN. Not Leibovich 2003. magent does not stage or read pathology. Not a diagnosis. Not a medical device.

van der Helm-van Mil 2007 Leiden prediction rule for recent-onset undifferentiated arthritis (Figure 1 / Table 2). Age × 0.02, female 1, small joints 0.5, symmetric 0.5, upper 1 or upper-and-lower 1.5, 100-mm morning-stiffness VAS 0/1/2, tender and swollen counts 0/0.5/1, CRP mg/L 0/0.5/1.5, RF 1, anti-CCP 2. Round to nearest 0.0 or 0.5. Bands ≤6 low, >6 and <8 indeterminate, ≥8 high. Not a diagnosis of RA. magent does not examine joints or assay serologies.

Clive 2014 LENT score for malignant pleural effusion: pleural LDH IU/L (<1500 → 0, >1500 → 1), ECOG 0-4 (0→0, 1→1, 2→2, 3-4→3), serum NLR as a number (<9 → 0, >9 → 1), tumour type (mesothelioma/haematological 0; breast/gynaecological/renal_cell 1; lung/other 2). Score 0-7: 0-1 low, 2-4 moderate, 5-7 high. Equality at 1500 or 9 is not scored. Not a diagnosis or treatment order.

Adult levothyroxine (LT4) full-replacement estimate: daily_lt4_mcg = weight_kg * 1.6 (ATA 2014). Weight in kg or lb. Not a prescription, TSH titration, pediatric or pregnancy-specific dose, or tablet strength. Lean-body-mass adjustment may apply; elderly and cardiac patients often start lower. Deterministic published arithmetic with citation.

Licurse 2010 AKI hydronephrosis points: history of hydronephrosis +4; nonblack (black=false) +1; recurrent UTI +1; obstruction-consistent diagnosis (mass, BPH, pelvic surgery, or neurogenic bladder) +1; absence of inpatient nephrotoxins, CHF, and prerenal AKI (pressor or sepsis) +1 each. Score 0-10. 2010 split only: <=2 low (HN 3.1%, HNRI 0.4%), >=3 higher (HN 15.7%, HNRI 4.7%). Not an imaging order. magent does not assign race or perform ultrasound.

Light 1972 pleural fluid criteria: exudate if protein ratio > 0.5, LDH ratio > 0.6, or pleural LDH > two-thirds the laboratory LDH ULN. ULN is required; magent does not assume 200 U/L. Strictly greater than those cutoffs. Deterministic published arithmetic with citation; not a diagnosis of cause, not Heffner's abbreviated criteria, and not a chest x-ray interpretation.

Lille model (Louvet 2007) from age, albumin, bilirubin at day 0 and day 7, creatinine, and PT seconds or INR. formula=pt or formula=inr is required; magent does not swap them. Score 0-1 with the published 0.45 cutoff. Deterministic published arithmetic with citation; not a medical device or a steroid order.

Gajic 2011 lung injury prediction score (Table 3): caller-assigned predisposing conditions, at most one high-risk surgery type plus emergency add-on, stacking trauma items, and risk modifiers including diabetes -1 only with sepsis. Score is a number; published observed range 0-15.5. Band low if <4, high if >=4 (ROC cutoff). Not an ARDS diagnosis. magent does not examine the patient or read imaging.

Liu 2004 respiratory clinical score: four caller-assigned 0-3 domains — respiratory_rate (age-banded Table 1 ordinal, not raw breaths/min), retractions, dyspnea, and auscultation. magent sums only (max 12) and does not count breaths or auscultate. Score only; Liu 2004 does not print mild/moderate/severe total-score cutoffs. Not a diagnosis or treatment order. Not PRAM. Not Westley 1978 croup.

LRINEC (Wong 2004): CRP ≥150 mg/L (4), WBC k/µL (<15 0, 15–25 1, >25 2), hemoglobin g/dL (>13.5 0, 11–13.5 1, <11 2), sodium <135 mmol/L (2), creatinine >141 µmol/L (2), glucose >10 mmol/L (1); max 13; cutoff ≥6. Deterministic published laboratory score with citation; not a diagnosis of necrotizing fasciitis and not an operative decision. A score below cutoff does not exclude disease.

De Jong 2013 MACOCHA from seven caller-assigned flags: Mallampati III or IV (5), OSA (2), reduced cervical mobility (1), mouth opening <3 cm (1), coma (1), SpO2 <80% (1), non-anesthesiologist (1). Total 0-12 (0 easy, 12 very difficult); high_risk at >=3. Not an intubation order. magent does not examine the airway, compute GCS, or measure SpO2.

Body 2014 MACS ACS probability from caller-assigned ECG ischaemia, worsening angina, right-arm radiation, vomiting, observed sweating, hypotension (SBP <100), Roche hs-cTnT ng/L, and ELISA H-FABP ng/mL. Table 2 rounded coefficients. Bands p<0.02 very_low, 0.02<=p<0.05 low, 0.05<=p<0.95 moderate, p>=0.95 high. magent does not interpret ECG or assay biomarkers. Not T-MACS, HEART, or EDACS. Not a diagnosis.

Maddrey discriminant function (1978) from patient and control prothrombin time in seconds plus bilirubin. Deterministic published formula with citation; not a diagnosis or steroid order.

Montgomery 1979 MADRS: ten caller-assigned integers 0-6 (apparent sadness, reported sadness, inner tension, reduced sleep, reduced appetite, concentration difficulties, lassitude, inability to feel, pessimistic thoughts, suicidal thoughts). Sum 0-60. magent does not interview. Montgomery 1979 printed no total-score severity bands; later 0-6/7-19/20-34/35-60 cutoffs are not applied. Not a diagnosis, not Hamilton 1960, not PHQ-9, and not a medical device.

Pocock 2013 MAGGIC integer score from 13 heart-failure predictors (age, EF, NYHA, creatinine, diabetes, not prescribed beta-blocker, SBP, BMI, HF duration >18 months, current smoker, COPD, male sex, not prescribed ACEI/ARB), including the published age×EF and SBP×EF extras. Returns integer score and Table 4 1-year and 3-year death probabilities for scores 0-50. Not a diagnosis, not a treatment order, not a reason to withhold therapy. magent does not examine the patient.

Holliday–Segar 1957 daily maintenance water from weight: 100 mL/kg for the first 10 kg, 50 mL/kg for the next 10 kg, 20 mL/kg thereafter. Returns daily and hourly milliliters. Deterministic published arithmetic with citation; not a treatment order or IV prescription.

Samsoon 1987 modified Mallampati: caller-assigned integer class 1-4 (I: soft palate, fauces, uvula, pillars; II: soft palate, fauces, uvula; III: soft palate, base of uvula; IV: soft palate not visible). Returns score, max 4, and a stable class label. Not original Mallampati 1985 three-class and not a Cormack-Lehane grade; magent does not look in the mouth or assign an intubation order.

Thieblemont 2017 MALT-IPI (IELSG-19): age ≥70, Ann Arbor III or IV, LDH > ULN; 1 point each, max 3. Low 0, intermediate 1, high ≥2. Deterministic published score with citation; not a lymphoma diagnosis or treatment choice; original MALT-IPI, not Revised MALT-IPI (no MMS; age is ≥70 not >60), not Shipp IPI. magent does not stage lymphoma or assay LDH.

Cerny 1987 Manchester score for small-cell lung cancer: LDH above laboratory ULN, sodium <132 mmol/L, ALP >1.5×ULN, bicarbonate <24 mmol/L, Karnofsky <60, extensive stage; 1 point each, max 6. Good 0–1, intermediate 2–3, poor ≥4. Deterministic published score with citation; not a diagnosis; not the BRCA Manchester score. magent does not stage the cancer, assay labs, or assign Karnofsky performance status.

Manning 1978 IBS symptoms. Six caller-assigned flags, 1 each, max 6: visible abdominal distension, pain relief with bowel movement, more frequent stools at pain onset, looser stools at pain onset, rectal mucus, incomplete evacuation. Score is the count of true flags (0-6). More symptoms made IBS more likely; no published cutoff. Count only. Not a diagnosis, not Rome III/IV. magent does not examine the patient.

Mean arterial pressure from cuff systolic and diastolic BP using diastolic + pulse pressure / 3. Conventional 1/3 estimate, not an invasive aortic mean. Deterministic published arithmetic with citation; not a treatment target.

Guilbert 2004 mAPI (PEAK Table I). Positive if 4+ wheeze episodes in one year (one MD-diagnosed) plus 1+ major or 2+ minor. Majors: parental asthma, MD atopic dermatitis, aeroallergen sensitization. Minors: milk/egg/peanut sensitization, wheezing unrelated to colds, eosinophils ≥4%. Not original API. Not m²API. Not an asthma diagnosis. magent does not examine the child. Not a medical device.

Pardanani 2018 MAPS hybrid clinical-molecular (Figure 3): advanced SM 2 (ASM, SM-AHN, or MCL; ISM/SSM 0), age >60 1, platelets <150×10^9/L 1, ALP above UNL 1, ASXL1/RUNX1/NRAS 1; max 6. Low ≤2, intermediate-1 3, intermediate-2 4, high ≥5. Not WHO SM, not ICC SM, not clinical-only Figure 1. magent does not sequence, assay ALP, or count platelets.

Jawhar 2019 mutation-adjusted risk score (MARS) for advanced systemic mastocytosis: age >60 (1), hemoglobin <10 g/dL (1), platelets <100×10^9/L (1), exactly one S/A/R mutation among SRSF2, ASXL1, RUNX1 (1) or two or more (2, not both). Max 5. Low 0–1 (training-set median OS not reached), intermediate 2 (3.9 y), high 3–5 (1.9 y). Not WHO SM criteria. magent does not sequence or assay labs.

Martin 2013 estimated LDL-C from total cholesterol, HDL, and triglycerides in mg/dL. Adjustable TG:VLDL-C factor from the published 180-cell table by non-HDL-C and TG strata. Not Friedewald factor 5, not Sampson, not a diagnosis or statin order.

MASCC risk index from Klastersky 2000: one burden-of-illness value (none_or_mild 5, moderate 3, severe 0) plus no hypotension (5), no COPD (4), solid tumor or hematologic malignancy without previous fungal infection (4), outpatient (3), no dehydration (3), and age <60 (2). Max 26; low-risk ≥21. Deterministic published arithmetic with citation; not an outpatient-chemotherapy order; magent does not read a blood pressure.

Swensen 1997 Mayo Clinic logistic probability of malignancy for a 4-30 mm radiologically indeterminate solitary pulmonary nodule. Inputs: age, current or former smoking, extrathoracic cancer diagnosed ≥5 years before the nodule, largest diameter in mm, caller-assigned spiculation, and caller-assigned upper-lobe location. Returns logit x and P = e^x / (1 + e^x). magent does not read the film. Not Gould 2007, not Brock, not a diagnosis, not a biopsy order, and not a medical device.

Schroeder 1987 ulcerative colitis disease-activity index (Mayo DAI): four caller-assigned integers 0-3 (stool frequency, rectal bleeding, endoscopy, physician global). magent sums only (max 12) and does not return later remission or activity-band cutoffs. magent does not count stools, examine the patient, or perform endoscopy. Not a diagnosis and not the Mayo SPN pulmonary-nodule model.

Khan 2020 modified Brain Injury Guidelines (mBIG), not original Joseph 2014 BIG. First-match worst-wins tier 3 then 2 then 1 from caller-assigned GCS, focal or pupillary abnormality, anticoagulant or antiplatelet excluding aspirin alone, EtOH >80 mg/dL, skull fracture, SDH mm, IPH mm and multiple IPH, SAH pattern and mm, any EDH, and IVH. Any EDH is mBIG 3. magent does not read CT. Adults with mild TBI and traumatic ICH. Not a diagnosis or neurosurgical plan. Not a medical device.

2017 McDonald typical CIS (Thompson 2018). mcdonald_ms iff typical_cis and no_better_explanation and: ≥2 attacks with ≥2 lesions; or ≥2 attacks with one lesion plus DIS; or CIS with ≥2 lesions plus MRI DIT or CSF-specific OCB; or CIS with one lesion plus DIS and MRI DIT or CSF-specific OCB. 2017: OCB may substitute for DIT when DIS is met. Symptomatic and cortical lesions count. Not PPMS. Not 2010 McDonald. magent does not read MRI or CSF. Not a diagnosis. Not a medical device.

2024 McDonald typical CIS (Montalban 2025). mcdonald_ms iff typical_cis and no_better_explanation and: ≥2 attacks with ≥2 lesions; or ≥2 attacks with one lesion plus DIS; or CIS with ≥2 lesions plus MRI DIT, OCB, or kappa FLC; or CIS with one lesion plus DIS and MRI DIT, OCB, or kappa FLC. DIS = ≥2 of 5 topographies (optic nerve added). Kappa FLC interchangeable with OCB. Not 2017 McDonald. Not PPMS. Not RIS. magent does not read MRI or assay CSF. Not a diagnosis. Not a medical device.

McMahon 2013 Table 3 rhabdomyolysis score: age ≤50→0, >50–≤70→1.5, >70–≤80→2.5, >80→3; female 1; Cr <1.4→0, 1.4–2.2→1.5, >2.2→3; Ca <7.5→2; CPK >40000→2; origin not seizure/syncope/exercise/statin/myositis→3; PO4 <4.0→0, 4.0–5.4→1.5, >5.4→3; HCO3 <19→2. Max 19. Caller-supplied labs and origin. Numeric total only; not a dialysis order.

Bech 2001 MDI: 12 caller-assigned integers 0-5 (at no time to all the time, last 2 weeks) covering 10 ICD-10/DSM-IV depression symptoms. Psychomotor (restless vs subdued) and appetite (reduced vs increased) each add the max of the pair, not the sum. Total 0-50. This paper's optimal total-score cutoff is 26. magent does not interview, apply Olsen 2003 HAM-D mapped bands, DSM-IV/ICD-10 algorithms, PHQ-9, QIDS, or Hamilton depression. Not a diagnosis.

Hirschfeld 2000 Mood Disorder Questionnaire (MDQ): thirteen caller-assigned yes/no lifetime manic/hypomanic items, 1 point each, max 13. Positive screen requires score ≥7 AND same_period AND moderate_or_serious_problem (that paper: sensitivity 0.73 and specificity 0.90 in a psychiatric outpatient sample). Not a bipolar diagnosis, not a medical device, and not Hirschfeld 2003 general-population cutoff tweaks. magent does not interview the patient.

IDMS 4-variable MDRD eGFR (Levey 2006) from standardized creatinine, adult age, sex, and caller-assigned Black. magent does not assign race. Deterministic published formula with citation; not CKD-EPI 2021 and not a dosing recommendation.

Williams 1993 US MEDPED total cholesterol cutoffs by age and relative degree (first, second, third, or general population). Meets the published criterion iff total cholesterol in mg/dL is greater than the table cutoff (mmol/L converted as mg/dL = mmol/L * 38.67). Total cholesterol only; not Dutch Lipid Clinic or Simon Broome. Not a medical device and not a diagnosis of familial hypercholesterolemia.

Mehran 2004 contrast-induced nephropathy risk score after PCI (eGFR model B). Points from hypotension, IABP, CHF, age >75, anemia, diabetes, contrast volume (1 per 100 mL), and caller eGFR. Returns integer score (max 41), risk group (low ≤5 through very_high ≥16), and development-set CIN percent. Not a CKD diagnosis; magent does not measure contrast or compute eGFR.

Mekhail 2005 Motzer extension: KPS <80, LDH >1.5x ULN, hemoglobin <LLN, corrected calcium >10 mg/dL, prior radiotherapy, >=2 metastatic sites; 1 point each, max 6. Favorable 0-1, intermediate 2, poor >=3. Not Motzer 1999 0 / 1-2 / >=3. Not Motzer 2002 time-to-treatment. Mekhail dropped no-prior-nephrectomy. Deterministic published score with citation; not an RCC diagnosis or treatment recommendation; not IMDC. magent does not assign KPS, assay LDH, hemoglobin, or calcium, or image metastases.

Kamath 2001 model for end-stage liver disease (MELD) from creatinine, bilirubin, INR, and etiology. meld = round(3.8*ln(bilirubin_mg_dL) + 11.2*ln(INR) + 9.6*ln(creatinine_mg_dL) + 6.4*etiology). etiology is 0 if cholestatic or alcoholic, else 1. Does not floor labs at 1.0 and does not include dialysis (later UNOS/OPTN). Not MELD-Na. Not a transplant listing or allocation order.

Kim 2021 MELD 3.0 from sex, bilirubin, INR, creatinine, sodium, albumin, and dialysis. meld_3 = round(1.33*(female) + 4.56*ln(bilirubin) + 0.82*(137-Na) - 0.24*(137-Na)*ln(bilirubin) + 9.09*ln(INR) + 11.14*ln(creatinine) + 1.85*(3.5-albumin) - 1.83*(3.5-albumin)*ln(creatinine) + 6). Creatinine 1.0-3.0 (dialysis 3.0); bilirubin and INR floor 1.0; sodium 125-137; albumin 1.5-3.5. Not original MELD or MELD-Na. Not a transplant listing or allocation order.

Cited OPTN/UNOS 2016 MELD-Na score. Agents must not invent MELD-Na from model memory; pay per request with x402 USDC on Base. Deterministic published score with citation. Not a treatment recommendation.

Mentzer index as MCV in fL divided by RBC count in millions per µL (Mentzer 1973 Lancet letter). Quotient <13 favors β-thalassaemia trait; >13 favors iron deficiency; 13 is indeterminate. Deterministic published arithmetic with citation. Not a diagnosis of thalassemia or iron deficiency; magent does not apply later cutoffs that are not in that letter.

Menza 2009 HIV-acquisition score for MSM. Four caller-assigned flags: meth or poppers in the prior 6 months (11), current or prior bacterial STI (4), ≥10 male partners in the prior year (3), unprotected anal intercourse with a positive- or unknown-status partner in the prior year (1). Max 19. Integer score only; no named strata or PrEP cutoff. Not a diagnosis, PrEP order, or test-and-treat protocol. Not HIRI-MSM or SexPro. magent does not take a sexual history.

Johansen 1990 Mangled Extremity Severity Score (MESS): caller-assigned skeletal/soft-tissue energy 1-4, limb ischemia 1-3 (doubled if ischemia time >6 hours), shock 0-2, and age points (<30 → 0, 30-50 → 1, >50 → 2). Max 14. MESS ≥7 predicted amputation with 100% accuracy in that series (mess_band 0-6 or >=7). Deterministic published arithmetic with citation. Not an amputation or limb-salvage protocol; magent does not examine the limb. Not later papers' cutoff of 8.

Mazzaferro 2018 Metroticket 2.0 AFP-adjusted-to-HCC-size 70% 5-year HCC-specific survival criteria. meets_70pct_hcc_specific_survival is true iff AFP <200 ng/mL and tumor_count + largest_cm <=7, or 200<=AFP<400 and sum <=5, or 400<=AFP<=1000 and sum <=4. AFP >1000 never meets. Not Milan, UCSF, Metroticket 1.0 contours, or competing-risk survival percents. magent does not interpret imaging or assay AFP. Not a medical device or transplant listing.

Bello-Chavolla 2018 METS-IR: ln(2×glucose_mg_dl + triglycerides_mg_dl)×BMI / ln(HDL_mg_dl), natural log, two decimals. Supply glucose, triglycerides, and HDL each as exactly one of mg/dL or mmol/L (glucose ×18, TG ×88.57, HDL ×38.67). BMI is caller-supplied (10–80). highest_quartile_t2d is true only when METS-IR > 50.39 (derivation highest T2D-risk quartile). Not a diabetes diagnosis, not HOMA-IR/HOMA2, and not a treatment threshold.

MEWS from Subbe 2001 Table 1: systolic BP, heart rate, respiratory rate, temperature (°C), and caller-assigned AVPU (alert/voice/pain/unresponsive) summed to a 0–14 total. Returns score_ge_5 because scores ≥5 were associated with increased risk of death or ICU/HDU. Deterministic published arithmetic with citation; not NEWS2; not an ICU-admission order.

Wolfe 1999 myasthenia gravis activities of daily living (MG-ADL) profile: eight caller-assigned integers 0-3 (talking, chewing, swallowing, breathing, brush_comb, arise_chair, double_vision, eyelid_droop), summed 0-24. magent does not examine the patient. Wolfe 1999 correlated MG-ADL with QMG; that is not a conversion. Not QMG, not MGFA class. Score and max_score only; no severity band. Not a medical device.